MBRX 8-K 2026-09-29

Moleculin Biotech, Inc. (MBRX) 8-K dated 2026-09-29 — accession 0001437749-26-031419. This URL is the filing, not the MBRX hub.

Moleculin Biotech, Inc. (MBRX) is a biotechnology company listed on US.

Moleculin Biotech, Inc. filed a 8-K on 2026-09-29. Accession 0001437749-26-031419.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported MBRX revenue for 2025-12-31 was $0. Net income was -$33.6M. MBRX currently screens at market cap $8.2M.

Not investment advice. The MBRX SEC hub lists recent forms. The stock page is the research view.